{"schema_version":"secwatch.filing_event.v1","accession":"0000072331-25-000074","form_type":"8-K/A","ticker":"NDSN","cik":"0000072331","company_name":"NORDSON CORP","filed_at":"2025-06-11T23:59:59+00:00","discovered_at":"2026-05-14T18:02:51.106512+00:00","generated_at":"2026-05-19T14:29:03.387300+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Nordson separation agreement for departing segment leader Lovass: $832,759 cash, continued vesting","bullets":["Stephen Lovass ceased as Medical and Fluid Solutions segment leader; assists transition until June 1, 2025, then separates.","Receives $832,759 cash (severance plus COBRA) and pro-rata FY2025 annual incentive under separation agreement.","Stock options granted on/before Dec 1, 2022 continue vesting; exercisable until June 1, 2030 or original expiry.","Restricted shares/units from same period vest pro-rata; PSUs from Dec 1, 2022 vest pro-rata based on actual performance.","One-year non-compete, non-solicitation; indefinite confidentiality, non-disparagement; outplacement up to $10k, financial planning up to $5k."],"urls":{"canonical":"https://secwatch.observer/filing/0000072331-25-000074","json":"https://secwatch.observer/filing/0000072331-25-000074.json","markdown":"https://secwatch.observer/filing/0000072331-25-000074.md","text":"https://secwatch.observer/filing/0000072331-25-000074.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/72331/000007233125000074/0000072331-25-000074-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/72331/000007233125000074/ndsn-20250428.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T14:29:03.387300+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"540d541c5d","claim":"Stephen Lovass departed as segment leader for the Medical and Fluid Solutions Segment at NORDSON CORP.","evidence_excerpt":"the Original Form 8-K reported that, on April 28, 2025, Stephen Lovass ceased to serve as segment leader for the Medical and Fluid Solutions Segment of Nordson Corporation","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/72331/000007233125000074/0000072331-25-000074-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ceased to serve"},{"label":"Role","value":"segment leader for the Medical and Fluid Solutions Segment"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}